Company Registration No. 16389258 (England and Wales)
BMC PHARMA LIMITED
Unaudited accounts
for the year ended 30 April 2026
BMC PHARMA LIMITED
Unaudited accounts
Contents
BMC PHARMA LIMITED
Company Information
for the year ended 30 April 2026
Director
CHIREWA BLESSING MWAKUNDWI
Company Number
16389258 (England and Wales)
Registered Office
39 Tucker Drive
Witham
Essex
CM8 1FA
England
BMC PHARMA LIMITED
Statement of financial position
as at 30 April 2026
Cash at bank and in hand
983
-
Creditors: amounts falling due within one year
(6,363)
-
Net current assets
12,620
-
Total assets less current liabilities
22,590
-
Creditors: amounts falling due after more than one year
(3,607)
-
Called up share capital
1
-
Profit and loss account
18,982
-
Shareholders' funds
18,983
-
For the year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 8 June 2026 and were signed on its behalf by
CHIREWA BLESSING MWAKUNDWI
Director
Company Registration No. 16389258
BMC PHARMA LIMITED
Notes to the Accounts
for the year ended 30 April 2026
BMC PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 16389258. The registered office is 39 Tucker Drive, Witham, Essex, CM8 1FA, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Motor vehicles
Computer equipment
Total
Cost or valuation
At cost
At cost
Additions
12,750
480
13,230
At 30 April 2026
12,750
480
13,230
Charge for the year
3,188
72
3,260
At 30 April 2026
3,188
72
3,260
At 30 April 2026
9,562
408
9,970
Amounts falling due within one year
BMC PHARMA LIMITED
Notes to the Accounts
for the year ended 30 April 2026
6
Creditors: amounts falling due within one year
2026
2025
Taxes and social security
3,607
-
7
Creditors: amounts falling due after more than one year
2026
2025
Taxes and social security
3,607
-
8
Average number of employees
During the year the average number of employees was 0 (2025: 0).